impact:

taiho.co.jp

Taiho Pharmaceutical Co., Ltd. (大鵬薬品工業, Taihō Yakuhin Kōgyō) is a Japanese pharmaceutical company, and a subsidiary of Otsuka Holdings, which focuses on developing cancer treatments. Taiho, headquartered in Tokyo, Japan, is an R&D-driven specialty pharma focusing on the three fields of oncology, allergies and immunology, and urology. Being Japan's second-largest pharmaceutical company by prescription oral oncology sales, Taiho covers oncology related therapeutic areas including stomach cancer, colorectal cancer, pancreatic cancer, and breast cancer. Taiho also engages in research and development, manufacturing, and the marketing of pharmaceutical products. The company is principally active in the prescription market, but also develops over-the-counter medication, and is a full member of the Japan Pharmaceutical Manufacturers Association (JPMA). More information...

According to PR-model, taiho.co.jp is ranked 227,207th in multilingual Wikipedia, in particular this website is ranked 17,803rd in Japanese Wikipedia.

The website is placed before loadoutroom.com and after ukhillwalking.com in the BestRef global ranking of the most important sources of Wikipedia.

#Language
PR-model F-model AR-model
227,207th place
317,732nd place
274,085th place
17,803rd place
26,439th place
15,687th place
707,036th place
654,743rd place
543,973rd place
172,597th place
257,919th place
327,584th place